Gastroenterology
Volume 129, Issue 2 , Pages 494-503 , August 2005

Survival After Liver Transplantation in Patients With Hepatic Iron Overload: The National Hemochromatosis Transplant Registry

These data were presented in part at the Plenary Session of the Annual Meeting of the American Association for the Study of Liver Diseases, 2001.

  • Kris V. Kowdley

      Affiliations

    • University of Washington, Seattle, Washington
    • Corresponding Author InformationAddress requests for reprints to: Kris V. Kowdley, MD, Professor of Medicine, University of Washington, Box 356174, Seattle, Washington 98195.fax: (206) 598-3884.
  • ,
  • David J. Brandhagen

      Affiliations

    • Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Robert G. Gish

      Affiliations

    • California Pacific Medical Center, San Francisco, California
  • ,
  • Nathan M. Bass

      Affiliations

    • University of California at San Francisco, San Francisco, California
  • ,
  • Jeffrey Weinstein

      Affiliations

    • Baylor University Medical Center, Dallas, Texas
  • ,
  • Michael L. Schilsky

      Affiliations

    • New York Weill Cornell Medical Center and Mount Sinai School of Medicine, New York, New York
  • ,
  • Robert J. Fontana

      Affiliations

    • University of Michigan, Ann Arbor, Michigan
  • ,
  • Timothy McCashland

      Affiliations

    • University of Nebraska, Omaha, Nebraska
  • ,
  • Scott J. Cotler

      Affiliations

    • Rush University, Chicago, Illinois
  • ,
  • Bruce R. Bacon

      Affiliations

    • St. Louis University, St. Louis, Missouri
  • ,
  • Emmet B. Keeffe

      Affiliations

    • Stanford University, Stanford, California
  • ,
  • Fredric Gordon

      Affiliations

    • Lahey Clinic, Burlington, Massachusetts
  • ,
  • Nayak Polissar

      Affiliations

    • The Mountain-Whisper-Light Statistical Consulting, Seattle, Washington; and the NHTR Study Group
  • ,
  • the National Hemochromatosis Transplant Registry

Received 22 October 2004 ,Accepted 20 April 2005.

References 

  1. Whittington CA , Kowdley KV . Review article (haemochromatosis) . Aliment Pharmacol Ther . 2002;16:1963–1975
  2. Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis . Ann Intern Med . 2003;138:627–633
  3. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis . Liver Transpl Surg . 1995;4:237–241
  4. Niederau C , Fischer R , Sonnenberg A , Stremmel W , Trampisch HJ , Strohmeyer G . Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis . N Engl J Med . 1985;313:1256–1262
  5. Adams PC , Speechley M , Kertesz AE . Long-term survival analysis in hereditary hemochromatosis . Gastroenterology . 1991;101:368–372
  6. Niederau C , Fischer R , Purschel A , Stremmel W , Haussinger D , Strohmeyer G . Long-term survival in patients with hereditary hemochromatosis . Gastroenterology . 1996;110:1107–1119
  7. Pillay P , Tzoracoleftherakis E , Tzakis AG , Kakizoe S , Van Thiel DH , Starzl TE . Orthotopic liver transplantation for hemochromatosis . Transplant Proc . 1991;23:1888–1889
  8. Kilpe E , Krakauer H , Wren RE . An analysis of liver transplant experience from 37 transplant centers as reported to Medicare . Transplantation . 1993;56:554–561
  9. Tung BY, Farrell FJ, McCashland TM, Gish RG, Bacon BR, Keeffe EB, et al. Long-term follow-up after liver transplantation in patients with hepatic iron overload . Liver Transpl Surg . 1999;5:369–374
  10. Deugnier Y, Turlin B, le Quilleuc D, Moirand R, Loreal O, Messner M, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis (practical implications for the diagnosis of hemochromatosis) . Am J Surg Pathol . 1997;21:669–675
  11. Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, et al. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation . Hepatology . 2000;31:456–460
  12. Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, et al. Increased hepatic iron and cirrhosis (no evidence for an adverse effect on patient outcome following liver transplantation) . Hepatology . 2000;32:1200–1207
  13. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index . J Hepatol . 1998;29:257–262
  14. Ludwig J , Hashimoto E , Porayko MK , Moyer TP , Baldus WP . Hemosiderosis in cirrhosis (a study of 447 native livers) . Gastroenterology . 1997;112:882–888
  15. Brandhagen DJ . Liver transplantation for hereditary hemochromatosis . Liver Transpl . 2001;7:663–672
  16. Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, et al. Patient and graft survival after liver transplantation for hereditary hemochromatosis (implications for pathogenesis) . Hepatology . 2004;39:1655–1662
  17. Emond MJ , Bronner MP , Carlson TH , Lin M , Labbe RF , Kowdley KV . Quantitative study of the variability of hepatic iron concentrations . Clin Chem . 1999;45:340–346
  18. Raaka S , Huehnergarth KV , Kowdley KV , Bronner MP . Tissue typing for HFE mutations . Hepatology . 2002;35:977–978
  19. Kaplan EL , Meier P . Nonparametric estimation from incomplete observations . J Am Stat Assoc . 1958;53:457–481
  20. Hosmer DW , Lemeshow S . Applied survival analysis . New York: John Wiley & Sons; 2002;
  21. Villeneuve JP , Bilodeau M , Lepage R , Cote J , Lefebvre M . Variability in hepatic iron concentration measurement from needle-biopsy specimens . J Hepatol . 1996;25:172–177
  22. Limaye AP , Bronner MP , Kowdley KV . Iron excess in the hepatic explant is associated with an increased risk of invasive fungal infection in liver transplant recipients . Hepatology . 2001;34:288A
  23. Byrne T, Balan V, Sachdev M, Petre S, Vargas H, Harison ME, et al. Long term outcome of liver transplantation for iron overload (analysis of the Scientific Registry of Transplant Recipients (SRTR) Database) . Gastroenterology . 2004;126(Suppl 2):A661
  24. Cecchetti G , Binda A , Piperno A , Nador F , Fargion S , Fiorelli G . Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis (polygraphic and echocardiographic evaluation) . Eur Heart J . 1991;12:224–230
  25. Dabestani A , Child JS , Perloff JK , Figueroa WG , Schelbert HR , Engel TR . Cardiac abnormalities in primary hemochromatosis . Ann N Y Acad Sci . 1988;526:234–244
  26. Lustbader ED , Hann HW , Blumberg BS . Serum ferritin as a predictor of host response to hepatitis B virus infection . Science . 1983;220:423–425
  27. Piperno A, Fargion S, D’Alba R, Roffi L, Fracanzani AL, Vecchi L, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection . J Hepatol . 1992;16:364–368
  28. Deugnier Y, Battistelli D, Jouanolle H, Guyader D, Gueguen M, Loreal O, et al. Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients . J Hepatol . 1991;13:286–290
  29. Bullen JJ , Spalding PB , Ward CG , Gutteridge JM . Hemochromatosis, iron and septicemia caused by Vibrio vulnificus . Arch Intern Med . 1991;151:1606–1609
  30. de Sousa M , Porto G . The immunological system in hemochromatosis . J Hepatol . 1998;28(Suppl 1):1–7
  31. Cardoso C, Porto G, Lacerda R, Resende D, Rodrigues P, Bravo F, et al. T-cell receptor repertoire in hereditary hemochromatosis (a study of 32 hemochromatosis patients and 274 healthy subjects) . Hum Immunol . 2001;62:488–499
  32. Arosa FA, Oliveira L, Porto G, da Silva BM, Kruijer W, Veltman J, et al. Anomalies of the CD8+ T cell pool in haemochromatosis (HLA-A3-linked expansions of CD8+CD28- T cells) . Clin Exp Immunol . 1997;107:548–554
  33. Porto G, Vicente C, Teixeira MA, Martins O, Cabeda JM, Lacerda R, et al. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis . Hepatology . 1997;25:397–402
  34. Arosa FA, da Silva AJ, Godinho IM, ter Steege JC, Porto G, Rudd CE, et al. Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis . Scand J Immunol . 1994;39:426–432

 Supported by NIH grants DK 54698, DK 02957, and DK 38215.

PII: S0016-5085(05)00874-7

doi: 10.1053/j.gastro.2005.05.004

Gastroenterology
Volume 129, Issue 2 , Pages 494-503 , August 2005